Advanced Search

 

Study ID Status Title Patient Level Data
112571 Completed A double-blind, randomized, placebo controlled Phase II study to evaluate the pharmacodynamics, safety, tolerability, and pharmacokinetics of Single Doses of the Oral Motilin Receptor Agonist GSK962040, in critically ill male and female patients with enteral feed intolerance Study Listed on ClinicalStudyDataRequest.com
112574 Completed A Phase III study to demonstrate the antiviral activity and safety of dolutegravir in HIV-1 infected adult subjects with treatment failure on an integrase inhibitor containing regimen.
112576 Withdrawn Safety and immunogenicity of GSK 15574484A vaccine in adults at occupational risk for influenza A (H5N1) exposure
112581 Completed An open-label primary vaccination study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis vaccine Poliorix administered as a three-dose primary vaccination course at 2, 3 and 4 months of age in healthy infants in China.
112582 Completed A multi-centre, double-blind, randomised, parallel-group, active controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263, WR238605) in subjects with Plasmodium vivax malaria. Study Listed on ClinicalStudyDataRequest.com
112584 Completed Immunogenicity and safety of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib (Infanrix-IPV+Hib™) in infants
112593 Completed Utility of the cantharidin-induced skin blister assay for evaluation of anti-inflammatory effects of macrolides in healthy volunteers
112595 Completed Impact on nasopharyngeal carriage, acute otitis media, immunogenicity and safety of GSK Biologicals’ pneumococcal conjugate vaccine 1024850A Study Listed on ClinicalStudyDataRequest.com
112597 Completed Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
112598 Completed Adherence of patients taking 5ARI vs 5ARI + alpha blocker combination therapy in Enlarged Prostate
112599 Completed Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
112602 Terminated Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
112604 Completed Comparison of Healthcare Utilization and Costs in Patients with Asthma who Fluticasone/Salmeterol Inhalation Powder versus other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.
112605 Completed Outcomes for Medicare asthma patients taking fluticasone propionate/salmeterol xinafoate combination versus Inhaled Corticosteroids or other combination therapy
112606 Completed Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
112607 Completed Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
112608 Completed Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects that Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
112609 Completed Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate–Salmeterol Combination Versus Other Maintenance Therapies
112611 Completed Prescription Patterns, Resource Utilization & Costs - Add-on Therapy with Anti Dipeptidyl Peptidase-IVs vs rosiglitazone
112617 Completed Impact of Migraine on Work Productivity in Patients Treated with a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
112620 Active not recruiting A Phase II, Randomised, Multi-Centre Study Evaluating Lapatinib in Combination with Vinorelbine or Capecitabine in Women with ErbB2 Overexpressing Metastatic Breast Cancer
112626 Completed A Multi-Center, Open-Label, Continuation Trial LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE) who Completed the Phase 2 Protocol LBSL02
112630 Completed Non-steroidal anti-inflammatory drugs alone or with a triptan and reports of transition from episodic to chronic migraine
112640 Completed Immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ pneumococcal vaccine GSK1024850A following primary and booster vaccination of healthy Japanese children Study Listed on ClinicalStudyDataRequest.com
112646 Completed Outcomes and Costs Associated with initiating Maintenance Treatment with Fluticasone Propionate 250mcg/Salmeterol xinafoate 50mcg Combination (FSC) Versus Anticholinergics including Tiotropium (TIO) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.